ClearPoint Neuro, Inc. Common Stock CLPT
$9.06
+3.31%
at last close
Market Cap$281.12 million
P/E Ratio—
Div Yield—
Volume117.8K
52-Week Range
$8.27$30.10
Analyst Ratings
- Consensus
- Buy — 2 Buy · 0 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $24.00 (+164.9% upside)
Key Stats
- Today's Range
- $8.81 – $9.11
- 50-Day Range
- $8.27 – $16.49
- 52-Week Range
- $8.27 – $30.10
- Volume
- 118K shs
- Average Volume
- 691K shs
- Market Cap
- $281.12 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.15%
- Days to Cover
- 1.00
About ClearPoint Neuro, Inc. Common Stock
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
Related Stocks
Compare head-to-head: CLPT vs SYK·CLPT vs BSX·CLPT vs MDLN·CLPT vs RMD
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.